A Randomised, Placebo Controlled Trial of Azithromycin for the Prevention of Chronic Lung Disease of Prematurity in Preterm Infants

Trial Profile

A Randomised, Placebo Controlled Trial of Azithromycin for the Prevention of Chronic Lung Disease of Prematurity in Preterm Infants

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Therapeutic Use
  • Acronyms TINN2
  • Most Recent Events

    • 22 Jun 2016 This trial was prematurely ended in Hungary according to the European Clinical Trials Database.
    • 09 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top